Amoxicillin-Clavulanate Extended-Release Tablets 1000mg/62.5mg from Japan
XR formulation combining amoxicillin and clavulanate for twice-daily dosing in respiratory infections. This mixed penicillin-based antibiotic in measured tablet doses for retail qualifies under HTS 3004.10.50.49 'other combination antibiotics'.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include dissolution profile testing for extended-release verification
• Ensure child-resistant blister packaging for retail compliance
• Monitor for DEA scheduling if combined with controlled substances